WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016102179) HF AUXILIARY AGENT, MEDICAL SYSTEM, AND METHOD FOR THE SELECTIVE TREATMENT OF CANCER TISSUE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/102179    International Application No.:    PCT/EP2015/078768
Publication Date: 30.06.2016 International Filing Date: 07.12.2015
IPC:
A61K 41/00 (2006.01), A61K 47/48 (2006.01), A61P 35/00 (2006.01), A61B 18/14 (2006.01)
Applicants: OLYMPUS WINTER & IBE GMBH [DE/DE]; Kuehnstr. 61 22045 Hamburg (DE)
Inventors: NOACK, Andreas; (DE)
Agent: SEEMANN & PARTNER; Raboisen 6 20095 Hamburg (DE)
Priority Data:
10 2014 226 903.2 23.12.2014 DE
Title (DE) HF-HILFSSTOFF, MEDIZINISCHES SYSTEM UND VERFAHREN ZUM SELEKTIVEN BEHANDELN VON KREBSGEWEBE
(EN) HF AUXILIARY AGENT, MEDICAL SYSTEM, AND METHOD FOR THE SELECTIVE TREATMENT OF CANCER TISSUE
(FR) ADJUVANT HF, SYSTÈME MÉDICAL ET PROCÉDÉ DE TRAITEMENT SÉLECTIF DES TISSUS CANCÉREUX
Abstract: front page image
(DE)Die Erfindung betrifft einen HF-Hilfsstoff sowie ein medizinisches System (2) und ein Verfahren zum selektiven Behandeln von Krebsgewebe (6). Ein Molekül (24) des HF-Hilfsstoffs umfasst eine spezifisch mit einem Oberflächenmerkmal (22) einer Krebszelle (20) zusammenwirkende erste Gruppe (26) und eine an diese erste Gruppe (26) angekoppelte polare zweite Gruppe (28).
(EN)The invention relates to an HF auxiliary agent as well as to a medical system (2) and a method for selectively treating cancer tissue (6). A molecule (24) of the HF auxiliary agent comprises a first group (26) that specifically interacts with a surface feature (22) of a cancer cell (20) as well as a polar second group (28) that is coupled to said first group (26).
(FR)L'invention concerne un adjuvant HF ainsi qu'un système médical (2) et un procédé de traitement sélectif des tissus cancéreux (6). Une molécule (24) de l'adjuvant HF comprend un premier groupe (26) qui coopère spécifiquement avec une caractéristique de surface (22) d'une cellule cancéreuse (20) et un second groupe (28) polaire accouplé à ce premier groupe (26).
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: German (DE)
Filing Language: German (DE)